Latest Breaking News On - Bavarian nordic - Page 6 : comparemela.com

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Anders gersel pedersenHeidi hunterLinette munksgaard andersenThomas alex bennekovKaren merete jensenGraham morrellLuc debruyneAnne louise eberhardMontse montanerFrank verwielCompany announcementBavarian nordicVice president investor relations

Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript

EBS earnings call for the period ending March 31, 2024.

White houseDistrict of columbiaUnited statesJoe papaJessica fyePaul williamsBaltimore bayviewHealth canadaDepartment of defenseEmerson groupStrategic nationalNational safety councilEmergent biosolutionsRich lindahlChief executiveMotley fool stock advisor

Emergent BioSolutions to lay off 300 workers, close Maryland plants

Emergent BioSolutions to lay off 300 workers, close Maryland plants
capitalgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalgazette.com Daily Mail and Mail on Sunday newspapers.

United statesJoe papaDrug administrationExchange commissionBaltimore sunEmergent biosolutionsEast baltimoreBavarian nordicWashington business journal

Emergent BioSolutions Reports First Quarter 2024 Financial

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of.

United statesJoe papaAssal hellmerJosephc papaCompany cantonUs department of defenseCompany camdenDevelopment expensesExchange commissionEmergent biosolutions incFirst quarterNet incomeDiluted shareSegment gross marginSegment adjusted gross marginAnthrax vaccine adsorbed

Emergent BioSolutions Reports First Quarter 2024 Financial Results

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 millionUpdates FY 2024 guidance .

United statesJosephc papaJoe papaAssal hellmerEmergent biosolutions incExchange commissionDevelopment expensesCompany camdenUs department of defenseCompany cantonFirst quarterNet incomeDiluted shareSegment gross marginSegment adjusted gross marginAnthrax vaccine adsorbed